Alpha Tau Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	12.66	6.69	23.85	16.17	1.84
Short-Term Investments	69.13	98.69	8.08	30.42	26.84
Cash & Cash Equivalents	81.79	105.38	31.93	46.59	28.68
Cash Growth	-22.39%	229.99%	-31.46%	62.45%	-
Other Current Assets	3.97	1.1	0.71	0.86	1.15
Total Current Assets	85.76	106.48	32.64	47.46	29.83
Property, Plant & Equipment	21.16	13.28	7.55	5.4	1.71
Other Long-Term Assets	0.47	0.39	2.03	0.14	0.02
Total Long-Term Assets	21.63	13.67	9.57	5.53	1.73
Total Assets	107.39	120.15	42.22	52.99	31.56
Accounts Payable	6.04	3.67	4.41	2.09	1.35
Current Debt	1.06	0.67	0	0	0
Total Current Liabilities	7.1	4.34	4.41	2.09	1.35
Long-Term Debt	12.21	4.52	0	0	0
Other Long-Term Liabilities	3.6	5.63	18.62	5.37	5.16
Total Long-Term Liabilities	15.81	10.15	18.62	5.37	5.16
Total Liabilities	22.91	14.49	23.03	7.45	6.51
Total Debt	13.28	5.19	0	0	0
Debt Growth	155.65%	-	-	-	-
Retained Earnings	-115.76	-86.6	-52.84	-25.57	-16.69
Shareholders' Equity	84.48	105.66	-34.78	-8.43	-0.19
Net Cash / Debt	68.51	100.19	31.93	46.59	28.68
Net Cash / Debt Growth	-31.62%	213.73%	-31.46%	62.45%	-
Net Cash Per Share	0.99	1.58	0.79	1.16	0.85
Working Capital	78.65	102.14	28.24	45.37	28.48
Book Value Per Share	1.22	1.66	-0.86	-0.21	-0.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).